Dr. Karl Vance Sitz, MD
- Medicare services, 2024
- 35
- Medicare patients, 2024
- 33
- Part D claims, 2024
- 141
- Publications
- 3
- Clinical trials
- 3
- Practice address
- 18 Corporate Hill Dr, Little Rock, AR 72205
- Practice phone
- Call (501) 224-1156
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Little Rock Allergy & Asthma Clinic PA
Little Rock, Arkansas
Find Dr. Sitz's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Karl Vance Sitz is an allergy and immunology (internal medicine) physician in Little Rock, Arkansas
Dr. Sitz practices at Little Rock Allergy & Asthma Clinic PA in Little Rock, Arkansas.
Dr. Sitz's NPI, 1518959691, was assigned on August 16, 2005. Dr. Sitz holds Arkansas license C7148.
- NPI
- 1518959691NPI Registry (opens in a new tab)
- NPI enumeration date
- August 16, 2005
- NPI status
- Active
- Practice phone
- (501) 224-1156
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Karl Vance Sitz practices at Little Rock Allergy & Asthma Clinic PA in Little Rock, Arkansas
Dr. Sitz's primary practice is Little Rock Allergy & Asthma Clinic PA, at 18 Corporate Hill Dr, Little Rock, AR 72205 in Pulaski County. The practice phone is (501) 224-1156.
- Little Rock Allergy & Asthma Clinic PA18 Corporate Hill Dr, Little Rock, AR 72205 · Pulaski CountyPhone(501) 224-1156
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Karl Vance Sitz is affiliated with 1 site of care
Dr. Sitz's primary practice is Little Rock Allergy & Asthma Clinic PA in Little Rock, Arkansas.
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Karl Vance Sitz's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sitz practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Little Rock Allergy & Asthma Clinic PA | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Karl Vance Sitz is one of 5 allergys and immunology (internal medicine) physicians in Arkansas
Allergy and immunology is Dr. Sitz's primary specialty in the NPI Registry, under taxonomy code 207RA0201X. Dr. Sitz is licensed in Arkansas.
Specialties and state licenses
- Allergy and immunology (internal medicine), ArkansasPrimary
Allergys and immunology (internal medicine) physicians near Dr. Sitz
Counts of allergys and immunology (internal medicine) physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Karl Vance Sitz billed Medicare for 35 services in 2024
CMS data shows 35 Medicare services from Dr. Sitz across 1 procedure code in 2024, for 33 Medicare patients. Medicare paid $221 for them. Every service was in an office.
Dr. Sitz's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Tests and treatments
- 2023: 5,0612024: 3599%
- Office and hospital visits
- 2023: 2452024: 0100%
Dr. Sitz's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Sitz?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Sitz and other allergys and immunology (internal medicine) physicians in Arkansas.
Source: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data
Dr. Karl Vance Sitz treated 33 Medicare patients in 2024, average age 71
CMS counts 33 Medicare patients who saw Dr. Sitz in 2024. The largest group is 65 to 74, with 19 patients. 70% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 0.90, where 1.00 is the Medicare average.
Dr. Sitz's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Sitz's Medicare patients by sex, 2024
- Women2164%
- Men1236%
Chronic conditions among Dr. Sitz's Medicare patients, 2024
- High cholesterol70%
- High blood pressure67%
- Arthritis58%
- Diabetes42%
- Asthma39%
Share of Medicare patients with each condition. A patient can have several.
Source: Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Karl Vance Sitz wrote 141 Medicare Part D claims in 2024
In 2024, Dr. Sitz wrote 141 Medicare Part D claims for 58 patients. 69% of them were for generic drugs. CMS names the drug for 72 of them, across 4 drugs with 11 or more claims each, at $10,827 in total drug cost. In 2023, CMS named 564 claims across 15 drugs.
Dr. Sitz's Part D claims by kind of drug, 2024
- Generic97 claims69%
- Brand-name44 claims31%
Dr. Sitz's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 5642024: 7287%
Drugs named by CMS: 4 in 2024, 15 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Karl Vance Sitz scored 76 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Sitz for performance year 2024, reported as part of a group.
Dr. Sitz's MIPS scores, performance year 2024
- 76of 100Final score
- 50.7of 100Quality
- 40of 100Improvement Activities
- 84of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Karl Vance Sitz has 3 publications on record
Dmand AI links 3 papers to Dr. Sitz, published from 2020 to 2022. Dr. Sitz's most frequent co-authors are Jonathan A. Bernstein, MD, Aleena Banerji, MD and Paula J. Busse, MD.
Dr. Sitz's papers by year, 2020 to 2022
Dr. Sitz's most frequent co-authors
- Jonathan A. Bernstein, MD2 shared papers
- Aleena Banerji, MD1 shared paper
- Paula J. Busse, MD1 shared paper
Recent publications by Dr. Sitz
See who Dr. Sitz researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Sitz works with, so you can find a warm path to the right allergys and immunology (internal medicine) physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Karl Vance Sitz has worked on 3 clinical trials
Dmand AI links Dr. Sitz to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Asthma, Respiratory Hypersensitivity and Hereditary Complement Deficiency Diseases. GlaxoSmithKline sponsors the most, 2. Open Payments lists research payments to Dr. Sitz that name 1 trial.
Clinical trials with Dr. Sitz by phase
- NonePhase 1: no trials
- NonePhase 2: no trials
- 1Phase 3: 1 trial
- 1Phase 4: 1 trial
Conditions in Dr. Sitz's trials
- Asthma
- Respiratory Hypersensitivity
- Hereditary Complement Deficiency Diseases
- Angioedemas, Hereditary
Investigators on the most trials with Dr. Sitz
- Armando Enrique Acevedo, MD2 shared trials
- Ana M. Acosta, MD2 shared trials
- Rafael Cardenas, MD2 shared trials
Recent clinical trials with Dr. Sitz
Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks (opens in a new tab)
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Karl Vance Sitz received $25,495 in industry payments from 2016 to 2025
CMS Open Payments shows 478 general payments to Dr. Sitz from 34 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 39% of the total. CSL Behring paid the most, $10,697. It also lists 36 research payments totaling $87,398 from 2016 to 2024, naming 1 clinical trial.
General payments to Dr. Sitz by program year, 2016 to 2025
General payments to Dr. Sitz by kind, 2016 to 2025
- Speaker and faculty fees$9,89739%
- Food and beverage$8,98835%
- Travel and lodging$4,39817%
- Honoraria$2,1008%
- Other$1130%
Companies that paid Dr. Sitz the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Karl Vance Sitz's profile data
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Karl Vance Sitz
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Karl Vance Sitz's NPI number?
Dr. Karl Vance Sitz's NPI number is 1518959691. It was assigned on August 16, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Karl Vance Sitz?
Dr. Karl Vance Sitz is an allergy and immunology (internal medicine) physician in Little Rock, Arkansas. The primary specialty in the NPI Registry is Allergy & Immunology (Internal Medicine) Physician (taxonomy code 207RA0201X).
Where does Dr. Karl Vance Sitz practice?
Dr. Sitz practices at 18 Corporate Hill Dr, Little Rock, AR 72205. Dr. Sitz's primary practice is Little Rock Allergy & Asthma Clinic PA in Little Rock, Arkansas.
What is Dr. Karl Vance Sitz's office phone number?
The practice phone on file for Dr. Sitz is (501) 224-1156.
What is Dr. Karl Vance Sitz's medical license number?
Dr. Sitz holds Arkansas license C7148.
Does Dr. Karl Vance Sitz accept Medicare?
Yes. CMS data shows Dr. Sitz billed Medicare for 35 services in 2024.
What is Dr. Karl Vance Sitz's MIPS score?
Dr. Sitz's MIPS final score for performance year 2024 is 76 out of 100, reported as part of a group.
How many Medicare patients does Dr. Karl Vance Sitz see?
CMS counts 33 Medicare patients who saw Dr. Sitz in 2024, with an average age of 71.
What services does Dr. Karl Vance Sitz bill to Medicare?
In 2024, Dr. Sitz's most billed Medicare services were allergy test or treatment (95115).
What drugs does Dr. Karl Vance Sitz prescribe most?
In 2024 Medicare Part D data, Dr. Sitz's most prescribed drugs by claims were Azelastine HCl, Ipratropium Bromide and Fluticasone Propionate.
Show 4 more questionsShow fewer questions
Has Dr. Karl Vance Sitz received payments from drug or device companies?
CMS Open Payments shows $25,495 in general payments to Dr. Sitz from 34 companies from 2016 to 2025. The largest total came from CSL Behring.
How long has Dr. Karl Vance Sitz been practicing?
Dr. Sitz's NPI was assigned in 2005.
Does Dr. Karl Vance Sitz do research?
Dmand AI links 3 publications to Dr. Sitz, published from 2020 to 2022. Dr. Sitz has worked on 3 clinical trials.
Who does Dr. Karl Vance Sitz publish with?
Dr. Sitz's most frequent co-authors are Jonathan A. Bernstein, MD (2 shared papers), Aleena Banerji, MD (1 shared paper) and Paula J. Busse, MD (1 shared paper).
Selling to allergy and immunology practices?
See allergys and immunology (internal medicine) physicians in Arkansas by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card